Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.51 |
| ▸ | PKM | P14618 | 2/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | LIPE | Q05469 | 1/20 | 0.49 |
| ▸ | SLC6A7 | Q99884 | 1/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.49 |
| ▸ | MEN1 | O00255 | 3/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1911514 | 0.87 | LMNA (0.56) | LMNAKDM4EPKMMAPK1HSD17B10 | |
| SCHEMBL5888121 | 0.80 | HSD17B10 (0.56) | LMNAKDM4EPKMMAPK1HSD17B10 | |
| SCHEMBL10861692 | 0.79 | MEN1 (0.50) | LMNAKDM4EPKMMAPK1HSD17B10 | |
| SCHEMBL10861683 | 0.79 | MEN1 (0.50) | LMNAKDM4EPKMMAPK1HSD17B10 | |
| SCHEMBL1919434 | 0.78 | MEN1 (0.73) | KDM4EPKMHSD17B10SLC6A7CYP1A2 | |
| SCHEMBL27580589 | 0.77 | KDM4E (0.62) | KDM4EPKMHSD17B10SLC6A7CYP1A2 | |
| SCHEMBL389894 | 0.76 | KDM4E (0.56) | LMNAKDM4EKMT2AMEN1ALDH1A1 | |
| SCHEMBL13149261 | 0.76 | HSD17B10 (0.65) | LMNAKDM4EMAPK1HSD17B10SLC6A7 | |
| SCHEMBL2856220 | 0.75 | GAA (0.61) | LMNAKDM4EHSD17B10SLC6A7CYP2C19 | |
| SCHEMBL9558198 | 0.74 | MEN1 (0.59) | LMNAKDM4EPKMMAPK1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130059803-A1 | BORON-CONTAINING SMALL MOLECULES | ANACOR PHARMACEUTICALS, INC. (US) | 2013-03-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130059803-A1 | BORON-CONTAINING SMALL MOLECULES | ETF1, POLR1C, DPM1 | LMNA 3138/4885KDM4E 3418/4885PKM 4663/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.